MINI FUTURE LONG - QUEST DIAGNOSTICS | Real-time Boerse Frankfurt Warrants 02:51:24 23/05/2024 pm IST | ||
| 5.43 EUR | +0.37% |
|
| Current month | +2.85% | ||
| 1 month | +20.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 5.43 | +0.37% |
| 22/24/22 | 5.41 | -2.87% |
| 21/24/21 | 5.57 | -1.24% |
| 20/24/20 | 5.64 | +0.71% |
| 17/24/17 | 5.6 | +2.19% |
Real-time Boerse Frankfurt Warrants
Last update May 23, 2024 at 02:51 pm IST
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0YZB |
| ISIN | DE000PZ0YZB6 |
| Date issued | 03/11/2023 |
| Strike | 83.25 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.99 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.75 € |
|---|---|
| Lowest since issue | 3.8 € |
| Spread | 0.05 € |
| Spread % | 0.91% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
